Intellia Therapeutics CEO John Leonard has, for the last couple years, found himself stuck in a financial Groundhog Day.

With a bunch of gene therapy and gene editing programs in clinical trials, CRISPR Therapeutics (NASDAQ: CRSP) has an ...

Genetic studies have revealed that when male mosquitoes lose their hearing, they also lose their sex lives. The surprising ...

Study links prenatal THC exposure to increased opioid addiction risk in later life, raising concerns for cannabis use during ...

A virologist named Beata Halassy recently made headlines after publishing a report of successfully treating her own breast ...

Selenoproteins are crucial for several biological functions, including the breakdown of harmful substances, immune system ...

On the wall of Dian Yang's office hangs a painting of a "Pandora's box of cancer" being opened with a molecular key. From ...

BEIJING, Nov. 16 (China Economic Net) - From November 14 to 15, the 11th Cell Biology Industry Conference (CBIC) opened in ...

Advancing four clinical-stage programs for hematologic malignancies and autoimmune diseases; multiple clinical data reports planned for 2025 -- -- Enrolling patients with LBCL (2L and after prior CD19 ...

SAN DIEGO, Nov. 15, 2024 /PRNewswire/ -- Shoreline Biosciences, Inc., a biopharmaceutical company developing disease modifying iNK cell therapies for autoimmune disorders, today announced its ...

Is the future of finance already written in the DNA of today's emerging technologies? Cathie Wood, CEO and CIO of Ark Invest, ...